AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 35 filers reported holding AXSOME THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $246,502 | +26.3% | 3,527 | +29.8% | 0.01% | +42.9% |
Q2 2023 | $195,244 | +23.5% | 2,717 | +6.0% | 0.01% | +16.7% |
Q1 2023 | $158,148 | -11.6% | 2,564 | 0.0% | 0.01% | -14.3% |
Q4 2022 | $178,839 | +72.0% | 2,564 | +9.9% | 0.01% | +40.0% |
Q3 2022 | $104,000 | +25.3% | 2,332 | +7.0% | 0.01% | +25.0% |
Q2 2022 | $83,000 | -7.8% | 2,179 | 0.0% | 0.00% | +33.3% |
Q1 2022 | $90,000 | +9.8% | 2,179 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $82,000 | +13.9% | 2,179 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $72,000 | -51.0% | 2,179 | 0.0% | 0.00% | -40.0% |
Q2 2021 | $147,000 | +10.5% | 2,179 | -7.4% | 0.01% | 0.0% |
Q1 2021 | $133,000 | -30.7% | 2,354 | 0.0% | 0.01% | -44.4% |
Q4 2020 | $192,000 | +14.3% | 2,354 | 0.0% | 0.01% | +12.5% |
Q3 2020 | $168,000 | -13.4% | 2,354 | 0.0% | 0.01% | -11.1% |
Q2 2020 | $194,000 | +47.0% | 2,354 | +4.7% | 0.01% | +28.6% |
Q1 2020 | $132,000 | -40.5% | 2,249 | +4.7% | 0.01% | -30.0% |
Q4 2019 | $222,000 | +416.3% | 2,149 | 0.0% | 0.01% | +400.0% |
Q3 2019 | $43,000 | -21.8% | 2,149 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $55,000 | +1733.3% | 2,149 | +148.2% | 0.00% | – |
Q1 2017 | $3,000 | – | 866 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |